Measurement of Tumor T2* Relaxation Times after Iron Oxide Nanoparticle Administration

SK Ramasamy, R Roudi, W Morakote… - JoVE (Journal of …, 2023 - jove.com
T2* relaxometry is one of the established methods to measure the effect of
superparamagnetic iron oxide nanoparticles on tumor tissues with magnetic resonance …

Cardiac T1 mapping in congenital heart disease: bolus vs. infusion protocols for measurements of myocardial extracellular volume fraction

N Al-Wakeel-Marquard, S Rastin, F Muench… - … International Journal of …, 2017 - Springer
Myocardial extracellular volume fraction (ECV) reflecting diffuse myocardial fibrosis can be
measured with T1 mapping cardiovascular magnetic resonance (CMR) before and after the …

Quantitative analysis of annulus fibrosus and nucleus pulposus derived from T2 mapping, diffusion-weighted and diffusion tensor MR imaging

TT Dao, P Pouletaut, L Robert, P Aufaure… - Computer Methods in …, 2013 - Taylor & Francis
Quantitative information on annulus fibrosus (AF) and nucleus pulposus (NP) is of interest in
early diagnosis of degenerated intervertebral disc (IVD) disease. In this present study, we …

T1 and extracellular volume fraction mapping in cardiac magnetic resonance: estimation of accuracy and precision of a novel algorithm

C Borrazzo, M Pacilio, N Galea… - Physics in Medicine …, 2019 - iopscience.iop.org
Magnetic resonance imaging is effective for non-invasive detection of myocardial diseases
by extracellular volume fraction (ECV) estimation. A new methodology for T1 and ECV …

[HTML][HTML] Measurement of diffuse ventricular fibrosis with myocardial T1 in patients with atrial fibrillation

JA Montgomery, W Abdallah, ZT Yoneda, E Brittain… - Journal of …, 2016 - Elsevier
Background Atrial fibrillation (AF) is associated with cardiac fibrosis, which can now be
measured noninvasively using T1-mapping with cardiac magnetic resonance imaging …

[HTML][HTML] The protein binding substance Ibuprofen does not affect the T1 time or partition coefficient in contrast-enhanced cardiovascular magnetic resonance

N Kawel, F Santini, T Haas, JM Froehlich… - Journal of …, 2012 - Elsevier
Background Contrast enhanced cardiovascular magnetic resonance (CMR) with T1
mapping enables quantification of diffuse myocardial fibrosis. Various factors, however, can …

[PDF][PDF] A guide to advanced MRI processing for clinical glioma research

P Clement, S Beun, F Arzanforoosh, M Castellaro… - 2024 - osf.io
Background To date, multiple advanced magnetic resonance imaging (MRI) methods
beyond conventional qualitative structural imaging for the diagnosis, prognosis, and …

[HTML][HTML] Myocardial T1 mapping and determination of partition coefficients at 3 tesla: comparison between gadobenate dimeglumine and gadofosveset trisodium

MS Nacif, FS Raman, N Gai, J Jones… - Radiologia …, 2018 - SciELO Brasil
Objective: To compare an albumin-bound gadolinium chelate (gadofosveset trisodium) and
an extracellular contrast agent (gadobenate dimeglumine), in terms of their effects on …

Dielectric encoding of medical images

TR McCollough, WJ McCollough - US Patent 9,111,334, 2015 - Google Patents
G06K 9/00(2006.01) G06T 700(2006.01)(57) ABSTRACT G06T II/00(2006.01) GOIR
33/02(2006.01) Microwave imaging apparatus and method for completely …

[HTML][HTML] Validation of a Method to Measure the T2 Value from the Color Mapping by Hue Value

T Hananouchi, M Nakayama - Current Medical Imaging, 2023 - ncbi.nlm.nih.gov
Background: Color mapping using quantitative MRI (Magnetic Resonance Imaging) is now
being reported in various medical fields to be useful in showing tissue conditions and …